Trending News

OCC Issues Bulletins on Customer Financial Record Protections and Politicized Debanking

Homebuyers Privacy Protection Act Signed Into Law, Restricting Trigger Leads

E-Verify Update: New Guidance for Employers on EAD Revocations

Responses to DOD Survey on Alternatives to TSCA High Priority Chemicals Due September 26, 2025

State Department Issues New, Immediate Requirement for Nonimmigrant Visa Applicants

Adjudicating Nonimmigrant Visa Applicants in Their Country of Residence — Implications for Employers and Employees

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Jupiter Neurosciences Launches Nugevia™: A Premium Longevity and Performance Supplement Line Grounded in Clinical Science
Posted On Monday, June 09, 2025
Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy
Posted On Monday, June 09, 2025
Keros Announces Return of $375 Million in Excess Capital to Stockholders
Posted On Monday, June 09, 2025
CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform
Posted On Monday, June 09, 2025
Dupixent® (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color
Posted On Saturday, June 07, 2025
RESTEM to Present Phase 2/3 IIMPACT Trial Design in Idiopathic Inflammatory Myopathy at EULAR 2025 Congress
Posted On Friday, June 06, 2025
Rakovina Therapeutics Announces the Closing of Oversubscribed Private Placement of $4.9 Million
Posted On Friday, June 06, 2025
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, June 06, 2025
Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
Posted On Friday, June 06, 2025
Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032
Posted On Friday, June 06, 2025
BioNTX to Join Strategic Partners at BIO International Convention, Showcasing North Texas as a Converging Life Sciences Powerhouse
Posted On Friday, June 06, 2025
Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model
Posted On Friday, June 06, 2025
Immix Biopharma Attends FDA CEO Forum in Washington DC
Posted On Friday, June 06, 2025
Soligenix Highlights Dr. Ellen Kim’s Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials
Posted On Friday, June 06, 2025
Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair
Posted On Friday, June 06, 2025
Apellis and Sobi Announce EMPAVELI® (pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN
Posted On Friday, June 06, 2025
Senti Bio to Participate in a Virtual Fireside Chat Hosted by Chardan Capital Markets, LLC
Posted On Friday, June 06, 2025
LEX Diagnostics Submits Dual Applications for FDA 510(k) Clearance and CLIA Waiver for Groundbreaking LEX VELO System
Posted On Friday, June 06, 2025
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
Posted On Friday, June 06, 2025
Candel Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
Posted On Friday, June 06, 2025
Celldex Therapeutics Announces Election of Denice Torres to its Board of Directors
Posted On Friday, June 06, 2025
Spur Therapeutics Presents Positive New Preclinical Data on Its Gene Therapy Candidate for GBA1 Parkinson’s Disease at 2025 GBA1 Meeting
Posted On Friday, June 06, 2025
Arcutis to Present New Long-Term Results of ZORYVE® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference
Posted On Friday, June 06, 2025
TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
Posted On Friday, June 06, 2025
Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer
Posted On Friday, June 06, 2025

Print